Informação sobre produto
- N-[3-[[5-Chloro-4-(1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-3-[[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]amino]benzamide
- Benzamide, N-[3-[[5-chloro-4-(1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-3-[[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]amino]-
THZ2 is a pyrimidine compound that exhibits apoptotic cell death with an effective dose of 0.5-2.0 mg/kg in mice. THZ2 has been shown to be effective in tumor models, inducing apoptosis in cancer cells and reducing the size of tumors. It also induces apoptosis in inflammatory diseases and inhibits the progression of metabolic disorders such as diabetes mellitus. THZ2 causes c-jun-n-terminal kinase (JNK) activation, which is involved in the regulation of growth and proliferation. This drug has been shown to induce a frequency shift in DNA, which might be useful for diagnosis purposes, as well as radiation therapy. The hydroxyl group on this molecule can be used for conjugation to other drugs or molecules by esterification reactions or amide bond formation to increase its bioavailability and reduce toxicity.
Propriedades químicas
Consulta técnica sobre: 3D-EPC81084 THZ2
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
